Anti-TNF-alpha (infliximab) in complex regional pain syndrome.
Phase of Trial: Phase II
Latest Information Update: 27 Nov 2010
At a glance
- Drugs Infliximab (Primary)
- Indications Complex regional pain syndromes
- Focus Therapeutic Use
- Acronyms InCRePaS
- 02 Feb 2010 New source identified and integrated (Netherlands Trial Register record no. NTR449).
- 19 Aug 2009 Status changed from not stated to completed as reported by ISRCTN: Current Controlled Trials record.
- 08 Nov 2006 New trial record.